1. Home
  2. ACHL vs FPAY Comparison

ACHL vs FPAY Comparison

Compare ACHL & FPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHL
  • FPAY
  • Stock Information
  • Founded
  • ACHL 2016
  • FPAY 2003
  • Country
  • ACHL United Kingdom
  • FPAY United States
  • Employees
  • ACHL N/A
  • FPAY N/A
  • Industry
  • ACHL Biotechnology: Biological Products (No Diagnostic Substances)
  • FPAY Diversified Commercial Services
  • Sector
  • ACHL Health Care
  • FPAY Consumer Discretionary
  • Exchange
  • ACHL Nasdaq
  • FPAY Nasdaq
  • Market Cap
  • ACHL 46.8M
  • FPAY 46.4M
  • IPO Year
  • ACHL 2021
  • FPAY N/A
  • Fundamental
  • Price
  • ACHL $1.14
  • FPAY $1.66
  • Analyst Decision
  • ACHL Buy
  • FPAY Strong Buy
  • Analyst Count
  • ACHL 2
  • FPAY 2
  • Target Price
  • ACHL $4.00
  • FPAY $3.25
  • AVG Volume (30 Days)
  • ACHL 266.7K
  • FPAY 409.0K
  • Earning Date
  • ACHL 11-14-2024
  • FPAY 11-14-2024
  • Dividend Yield
  • ACHL N/A
  • FPAY N/A
  • EPS Growth
  • ACHL N/A
  • FPAY N/A
  • EPS
  • ACHL N/A
  • FPAY N/A
  • Revenue
  • ACHL N/A
  • FPAY $134,563,007.00
  • Revenue This Year
  • ACHL N/A
  • FPAY $25.78
  • Revenue Next Year
  • ACHL N/A
  • FPAY $6.46
  • P/E Ratio
  • ACHL N/A
  • FPAY N/A
  • Revenue Growth
  • ACHL N/A
  • FPAY 24.46
  • 52 Week Low
  • ACHL $0.63
  • FPAY $0.97
  • 52 Week High
  • ACHL $1.76
  • FPAY $2.37
  • Technical
  • Relative Strength Index (RSI)
  • ACHL 55.79
  • FPAY 47.07
  • Support Level
  • ACHL $1.12
  • FPAY $1.60
  • Resistance Level
  • ACHL $1.18
  • FPAY $2.37
  • Average True Range (ATR)
  • ACHL 0.05
  • FPAY 0.20
  • MACD
  • ACHL -0.00
  • FPAY -0.02
  • Stochastic Oscillator
  • ACHL 33.33
  • FPAY 24.47

About ACHL Achilles Therapeutics plc

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

About FPAY FlexShopper Inc.

FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.

Share on Social Networks: